Pao-luh Tao
Miaoli, TNQ 35053, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
DBPR116, a Prodrug of BPRMU191, in Combination with Naltrexone as a Safer Opioid Analgesic Than Morphine via Peripheral Administration.
Journal: Journal of medicinal chemistry
Published: October 30, 2024
Dextromethorphan moderates reward deficiency associated with central serotonin transporter availability in 3,4-methylenedioxy-methamphetamine-treated animals.
Journal: Journal of the Chinese Medical Association : JCMA
Published: April 08, 2024
Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia.
Journal: Cell chemical biology
Published: October 02, 2023
Comparisons of stress-related neuronal activation induced by restraint in adult male rat offspring with prenatal exposure to buprenorphine, methadone, or morphine.
Journal: The Chinese journal of physiology
Published: April 21, 2023
Selective and antagonist-dependent µ-opioid receptor activation by the combination of 2-{[2-(6-chloro-3,4-dihydro-1(2H)-quinolinyl)-2-oxoethyl]sulfanyl}-5-phenyl-4,6-(1H,5H)-pyrimidinedione and naloxone/naltrexone.
Journal: Bioorganic chemistry
Published: August 06, 2021
Dextromethorphan Dampens Neonatal Astrocyte Activation and Endoplasmic Reticulum Stress Induced by Prenatal Exposure to Buprenorphine.
Journal: Behavioural neurology
Published: April 16, 2021
Morphine produces potent antinociception, sedation, and hypothermia in humanized mice expressing human mu-opioid receptor splice variants.
Journal: Pain
Published: February 11, 2020
Delta-opioid receptor antagonist naltrindole reduces oxycodone addiction and constipation in mice.
Journal: European journal of pharmacology
Published: February 15, 2019
The in vivo antinociceptive and μ-opioid receptor activating effects of the combination of N-phenyl-2',4'-dimethyl-4,5'-bi-1,3-thiazol-2-amines and naloxone.
Journal: European journal of medicinal chemistry
Published: November 26, 2018
BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine.
Journal: Neuropharmacology
Published: September 13, 2018
Convallatoxin enhance the ligand-induced mu-opioid receptor endocytosis and attenuate morphine antinociceptive tolerance in mice.
Journal: Scientific reports
Published: August 02, 2018
1-(2,4-Dibromophenyl)-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one: A Novel Opioid Receptor Agonist with Less Accompanying Gastrointestinal Dysfunction than Morphine.
Journal: Anesthesiology
Published: February 18, 2017
Last Updated: 09/26/2026